Predict your next investment

Non-Profit Foundation
abta.org

See what CB Insights has to offer

Investments

1

Portfolio Exits

1

Partners & Customers

1

About American Brain Tumor Association

Founded in 1973, the American Brain Tumor Association is a non-profit organization dedicated to funding brain tumor research. The ABTA is a catalyst for research-based breakthroughs in the causes, diagnosis and treatment of brain tumors, and recognized as the leading resource in patient-centered brain tumor information, education and support.

American Brain Tumor Association Headquarter Location

8550 W Bryn Mawr Ave Suite 550

Chicago, Illinois, 60631,

United States

773-577-8750

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing American Brain Tumor Association

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find American Brain Tumor Association in 1 Expert Collection, including Pharma Startups.

P

Pharma Startups

5,090 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

Latest American Brain Tumor Association News

American Brain Tumor Association Announces New Board of Directors Chair and Members

Jan 28, 2021

News provided by Share this article CHICAGO, Jan. 28, 2021 /PRNewswire/ -- The American Brain Tumor Association announced today the appointment of Carla Varner as Chair of the Board of Directors and newly-elected members Mitchel S. Berger, MD, Berthold and Belle N. Guggenheim professor and University of California, San Francisco Brain Tumor Center director and Danny Monson, CEO of State Logistics Services, Inc. Their terms began on January 1, 2021. Carla Varner, Chief Legal Officer and Managing Director of Franklin Monroe Administrative Services, LLC Mitchel S. Berger, MD, Berthold and Belle N. Guggenheim Professor and University of California, San Francisco Brain Tumor Center Director Danny Monson, CEO of State Logistics Services, Inc. In her new role as Board Chair, Carla Varner is responsible for leading the ABTA's dedicated board members and providing strategic governance for the organization. She will work closely with Ralph DeVitto, president and CEO of the ABTA, to enhance the organization's reputation as a leader in serving brain tumor patients and funding breakthrough brain tumor research. "As an ABTA board member for the past six years, I am confident in Carla's ability to lead the board through the impact of the pandemic and beyond," DeVitto said. Varner has served on the ABTA board since 2014 and is the chief legal officer and managing director of Franklin Monroe Administrative Services, LLC, a financial services company headquartered in Chicago, Illinois. In addition, the ABTA is proud to announce two newly-elected members joining the board in 2021: Danny Monson Danny Monson, CEO of States Logistics Services, Inc., has 29 years of experience in the warehouse and transportation industry. Monson's 19-year-old daughter Katie was diagnosed with a glioblastoma (GBM) in 2017. The KM Legacy Foundation was created by Katie in 2017 to raise money for brain cancer awareness and research. She passed away in 2018 from a GBM. Danny, his wife Jennifer, and their two daughters continue to lead the Foundation to advance progress in the fight against brain tumors. Danny and the entire Monson family are strong supporters of the ABTA. Mitchel S. Berger, MD Mitchel S. Berger, MD, FACS, FAANS, is the Berthold and Belle N. Guggenheim professor and UCSF's Brain Tumor Center director. He also served as past chair of UCSF's department of Neurological Surgery from 1997-2020. During his distinguished career, Dr. Berger has served as president of the American Association of Neurological Surgeons, president of the Society of Neuro-Oncology and president of the American Academy of Neurological Surgery. He has also been a director of the American Board of Neurological Surgery; a member of the Board of Directors of the American Association of Neurological Surgeons; and a member of the Blue Ribbon Panel for the National Cancer Moonshot Initiative. Dr. Berger has been a longtime volunteer for the ABTA. The 2021 American Brain Tumor Association Board of Directors: Carla Varner—Chair; Ram Subramanian—Vice Chair; Bob Kruchten—Treasurer; Brandon Starkoff—Secretary; Jim Reilly—Immediate Past Chair; and members — Mitchel S. Berger, M.D. ; Jackie Lemke; Danny Monson and Mindee Plugues. President & CEO

American Brain Tumor Association Investments

1 Investments

American Brain Tumor Association has made 1 investments. Their latest investment was in Forte Biosciences as part of their Grant - III on May 5, 2011.

CBI Logo

American Brain Tumor Association Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

5/10/2011

Grant - III

Forte Biosciences

$0.2M

Yes

1

Date

5/10/2011

Round

Grant - III

Company

Forte Biosciences

Amount

$0.2M

New?

Yes

Co-Investors

Sources

1

American Brain Tumor Association Portfolio Exits

1 Portfolio Exit

American Brain Tumor Association has 1 portfolio exit. Their latest portfolio exit was Forte Biosciences on April 13, 2017.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

4/13/2017

IPO

$991

1

Date

4/13/2017

Exit

IPO

Companies

Valuation

$991

Acquirer

Sources

1

American Brain Tumor Association Partners & Customers

1 Partners and customers

American Brain Tumor Association has 1 strategic partners and customers. American Brain Tumor Association recently partnered with National Cancer Institute on June 6, 2019.

Date

Type

Business Partner

Country

News Snippet

Sources

6/4/2019

Partner

National Cancer Institute

United States

American Brain Tumor Association FIBER ARTIST RECONSTRUCTS THE BRAIN TO SUPPORT THE ABTA. ABTA PARTNERS WITH NATIONAL CANCER INSTITUTE TO ACCELERATE RARE BRAIN TUMOR RESEARCH.

The American Brain Tumor Association is partnering with the National Cancer Institute 's NCI-CONNECT initiative to advance the understanding of rare adult brain tumors and CNS cancers to improve approaches to care and treatment .

1

Date

6/4/2019

Type

Partner

Business Partner

National Cancer Institute

Country

United States

News Snippet

American Brain Tumor Association FIBER ARTIST RECONSTRUCTS THE BRAIN TO SUPPORT THE ABTA. ABTA PARTNERS WITH NATIONAL CANCER INSTITUTE TO ACCELERATE RARE BRAIN TUMOR RESEARCH.

The American Brain Tumor Association is partnering with the National Cancer Institute 's NCI-CONNECT initiative to advance the understanding of rare adult brain tumors and CNS cancers to improve approaches to care and treatment .

Sources

1

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.